Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial

Jolien van Nimwegen; Esther Mossel; Robin Wijnsma; Greetje van Zuiden; Konstantina Delli; Alja Stel; Bert van der Vegt; Erlin Haacke; Lisette Olie; Leonie Los; Gwenny Verstappen; Sarah Pringle; Fred Spijkervet; Frans Kroese; Arjan Vissink; Suzanne Arends; Hendrika Bootsma

Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial

Jolien van Nimwegen, Esther Mossel, Robin Wijnsma, Greetje van Zuiden, Konstantina Delli, Alja Stel, Bert van der Vegt, Erlin Haacke, Lisette Olie, Leonie Los, Gwenny Verstappen, Sarah Pringle, Fred Spijkervet, Frans Kroese, Arjan Vissink, Suzanne Arends, Hendrika Bootsma

Translational Immunology Groningen (TRIGR)

Onderzoeksoutput › Academic

Originele taal-2	English
Aantal pagina's	3
Tijdschrift	Arthritis & Rheumatology
Volume	71
Status	Published - okt.-2019

Handle.net

Permanente koppeling

Citeer dit

van Nimwegen, J., Mossel, E., Wijnsma, R., van Zuiden, G., Delli, K., Stel, A., van der Vegt, B., Haacke, E., Olie, L., Los, L., Verstappen, G., Pringle, S., Spijkervet, F., Kroese, F., Vissink, A., Arends, S., & Bootsma, H. (2019). Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial. Arthritis & Rheumatology, 71.

@article{fbf51ddc53fa49348a7bbaec46dc016d,

title = "Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial",

author = "{van Nimwegen}, Jolien and Esther Mossel and Robin Wijnsma and {van Zuiden}, Greetje and Konstantina Delli and Alja Stel and {van der Vegt}, Bert and Erlin Haacke and Lisette Olie and Leonie Los and Gwenny Verstappen and Sarah Pringle and Fred Spijkervet and Frans Kroese and Arjan Vissink and Suzanne Arends and Hendrika Bootsma",

year = "2019",

month = oct,

language = "English",

volume = "71",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "Wiley",

}

van Nimwegen, J, Mossel, E, Wijnsma, R , van Zuiden, G , Delli, K , Stel, A , van der Vegt, B, Haacke, E, Olie, L, Los, L , Verstappen, G , Pringle, S , Spijkervet, F , Kroese, F , Vissink, A , Arends, S & Bootsma, H 2019, 'Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial', Arthritis & Rheumatology, vol. 71.

TY - JOUR

T1 - Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial

AU - van Nimwegen, Jolien

AU - Mossel, Esther

AU - Wijnsma, Robin

AU - van Zuiden, Greetje

AU - Delli, Konstantina

AU - Stel, Alja

AU - van der Vegt, Bert

AU - Haacke, Erlin

AU - Olie, Lisette

AU - Los, Leonie

AU - Verstappen, Gwenny

AU - Pringle, Sarah

AU - Spijkervet, Fred

AU - Kroese, Frans

AU - Vissink, Arjan

AU - Arends, Suzanne

AU - Bootsma, Hendrika

PY - 2019/10

Y1 - 2019/10

M3 - Meeting Abstract

SN - 2326-5191

VL - 71

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

ER -